Proteomics Intl Labs Ltd has released a press release.
December 2021 Quarterly Activities Report and Appendix 4C
Filed with ASX ·
6ix hasn’t read this filing yet.
Proteomics International Laboratories Ltd. on 6ix
Story so far
Earlier from Proteomics International Laboratories
- Proteomics secures major pharmacokinetic testing contract
- Proteomics receives $1.2 million in R&D tax incentive
- PromarkerD distribution network expands to Britain
- PromarkerD outperforms standard of care tests for DKD
- Proteomics awarded $100,000 manufacturing funding
Later from Proteomics International Laboratories
- Unique panel of biomarkers identified for oesophageal cancer
- PromarkerD completes pre-assessment for Medicare rebate
- New Clinical Advisory Board for PromarkerD global rollout
- March 2022 Quarterly Activities Report and Appendix 4C
- Proteomics awarded $400,000 funding to support manufacturing
Follow Proteomics International Laboratories into a list and get an email when it puts out news.
Follow Proteomics International Laboratories